49,363 Shares in Danaher Corporation $DHR Bought by HF Advisory Group LLC

HF Advisory Group LLC purchased a new position in Danaher Corporation (NYSE:DHR) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 49,363 shares of the conglomerate’s stock, valued at approximately $10,936,000. Danaher accounts for about 2.6% of HF Advisory Group LLC’s investment portfolio, making the stock its 3rd biggest position.

Several other institutional investors have also bought and sold shares of the company. Armstrong Advisory Group Inc. bought a new stake in shares of Danaher in the third quarter valued at approximately $1,003,000. Marquette Asset Management LLC lifted its position in shares of Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares in the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI purchased a new stake in shares of Danaher during the third quarter worth $14,338,000. Argus Investors Counsel Inc. boosted its holdings in shares of Danaher by 247.1% in the third quarter. Argus Investors Counsel Inc. now owns 7,282 shares of the conglomerate’s stock worth $1,613,000 after acquiring an additional 5,184 shares during the period. Finally, Davidson Trust Co. purchased a new position in shares of Danaher in the third quarter valued at $1,488,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.2%

Shares of DHR stock opened at $220.15 on Friday. The business has a 50-day moving average price of $211.38 and a two-hundred day moving average price of $194.62. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a market cap of $154.76 billion, a P/E ratio of 39.10, a price-to-earnings-growth ratio of 2.71 and a beta of 0.76.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the previous year, the company posted $0.77 EPS. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is 28.42%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DHR. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday. TD Cowen cut their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Guggenheim boosted their price target on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Finally, Wells Fargo & Company lowered their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $235.23.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.